港股异动 | 英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作

老虎资讯综合02-10

2月10日，英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作

消息面上，2月10日，英矽智能与康哲药业宣布在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据合作协议，双方将结合英矽智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，共同推进不少于2个研发项目的合作开发。同时，英矽智能有望就每个项目获得最高达数千万港元的研发费用支持。

大摩此前研报指出，英矽智能是AIDD领域的领先者，在技术验证与应用方面均取得实质性进展。其化学模型的执行力支撑其可重复的 “1-to-N” 创新创造引擎；随着生物学模型的人体验证逐步显现，其潜在上行弹性有望在整个行业进入广泛AIDD采用期时得到进一步释放。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1170483950?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","is_english":false,"pubTime":"2026-02-10 10:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170483950","market":"us","top_or_hot":-1,"title":"港股异动 | 英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作","media":"老虎资讯综合","content":"<html><head></head><body><p>2月10日，<a href=\"https://laohu8.com/S/03696\">英矽智能</a>涨超9%创新高，该公司与<a href=\"https://laohu8.com/S/00867\">康哲药业</a>达成数千万港元多个药物研发项目合作</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/aaa826703043b8ea12febc06de3cbce0\" title=\"\" tg-width=\"560\" tg-height=\"240\"/></p><p>消息面上，2月10日，英矽智能与 <a href=\"https://laohu8.com/S/00867.HK\">康哲药业 </a> 宣布在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据合作协议，双方将结合英矽智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，共同推进不少于2个研发项目的合作开发。同时，英矽智能有望就每个项目获得最高达数千万港元的研发费用支持。</p><p style=\"text-align: justify;\">大摩此前研报指出，英矽智能是AIDD领域的领先者，在技术验证与应用方面均取得实质性进展。其化学模型的执行力支撑其可重复的 “1-to-N” 创新创造引擎；随着生物学模型的人体验证逐步显现，其潜在上行弹性有望在整个行业进入广泛AIDD采用期时得到进一步释放。</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>港股异动 | 英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n港股异动 | 英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作\n</h2>\n\n<h4 class=\"meta\">\n\n2026-02-10 10:02 北京时间&nbsp;&nbsp;&nbsp;<strong>老虎资讯综合</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>2月10日，英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作消息面上，2月10日，英矽智能与 康哲药业  宣布在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据合作协议，双方将结合英矽智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，共同推进不少于2个研发项目的合作开发。同时，英矽智能...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IE00BVYPNQ40.USD","symbol_name":"GUINNESS ASIAN EQUITY INCOME \"C\" (USD) ACC","start_time":0,"source_url":"","article_id":"1170483950","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170483950","pubTimestamp":1770688943,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"2月10日，$英矽智能(03696)$涨超9%创新高，该公司与$康哲药业(00867)$达成数千万港元多个药物研发项目合作","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"IE00BVYPNQ40.USD":"GUINNESS ASIAN EQUITY INCOME \"C\" (USD) ACC","03696":"英矽智能","LU2488822045.USD":"ALLIANZ CHINA HEALTHY LIVING \"AT\" (USD) ACC","IE00BYV24P56.USD":"GUINNESS EMERGING MARKETS EQUITY INCOME \"C\" (USD) ACC","SG9999015952.SGD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (SGD) ACC","SG9999015978.USD":"利安颠覆性创新基金A","BK4588":"碎股","BK1191":"制药","IE00BGHQDM52.EUR":"GUINNESS ASIAN EQUITY INCOME \"C\" (EUR) ACC","IE00BVYPNP33.GBP":"GUINNESS ASIAN EQUITY INCOME \"C\" (GBP) ACC","BK4585":"ETF&股票定投概念","BK1593":"医美概念股","IE00BMCWC346.EUR":"GUINNESS EMERGING MARKETS EQUITY INCOME \"C\" (EUR) ACC","SG9999015945.SGD":"LionGlobal Disruptive Innovation Fund A SGD","SG9999004220.SGD":"Nikko AM Shenton Asia Dividend Equity Fund  SGD","SG9999015986.USD":"LIONGLOBAL DISRUPTIVE INNOVATION \"I\" (USD) ACC"},"translate_title":"Changes in Hong Kong stocks | Insilicon Intelligent rose more than 9% to a new high. The company and CMS have reached tens of millions of Hong Kong dollars in cooperation on multiple drug research and development projects","themeId":"7323b9e43cf2c98249ddbdcb6770aa68","isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/b0a8fa0bd1327e4734c55c1a7928c231","symbols_score_info":{"03696":1.5},"content_text":"2月10日，英矽智能涨超9%创新高，该公司与康哲药业达成数千万港元多个药物研发项目合作消息面上，2月10日，英矽智能与 康哲药业  宣布在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。根据合作协议，双方将结合英矽智能已验证的AI平台与AI赋能创新药研发能力，以及康哲药业经验丰富的研发团队和对疾病领域的深度认知，共同推进不少于2个研发项目的合作开发。同时，英矽智能有望就每个项目获得最高达数千万港元的研发费用支持。大摩此前研报指出，英矽智能是AIDD领域的领先者，在技术验证与应用方面均取得实质性进展。其化学模型的执行力支撑其可重复的 “1-to-N” 创新创造引擎；随着生物学模型的人体验证逐步显现，其潜在上行弹性有望在整个行业进入广泛AIDD采用期时得到进一步释放。","kind":"news","is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170483950","isCrawlerRequest":true}